.png){kind=icon}
返回
Does In Vitro Potency Predict Clinically Efficacious Concentrations?
.png){kind=icon}
OA
AI
DOI：10.1002/cpt.1846.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
The in vitro affinity of a compound for its target is an important feature in drug discovery, but what remains is how predictive in vitro properties are of in vivo therapeutic drug exposure. We assessed the relationship between in vitro potency and clinically efficacious concentrations for marketed small molecule drugs (n = 164) and how they may differ depending on therapeutic indication, mode of action, receptor type, target localization, and function. Approximately 70% of compounds had a therapeutic unbound plasma exposure lower than in vitro potency; the median ratio of exposure in relation to in vitro potency was 0.32, and 80% had ratios within the range of 0.007 to 8.7. We identified differences in the in vivo-to-in vitro potency ratio between indications, mode of action, target type, and matrix localization, and whether or not the drugs had active metabolites. The in vitro-assay variability contributions appeared to be the smallest; within the same drug target and mode of action the within-variability was slightly broader; but both were substantially less compared with the overall distribution of ratios. These data suggest that in vitro potency conditions, estimated in vivo potency, required level of receptor occupancy, and target turnover are key components for further understanding the link between clinical drug exposure and in vitro potency.
Keyword:
PLASMA-PROTEIN BINDING
COMPOUND PROMISCUITY
DRUG DISCOVERY
VIVO
PHARMACOKINETICS
INHIBITOR
TARGET
PHARMACODYNAMICS
PHARMACOLOGY
RECEPTOR
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
C
IF:
5.5
论文数:
8.6K
被引数:
1.9W
机构
引用论文
Pharmacokinetic Steady-States Highlight Interesting Target-Mediated Disposition Properties.png)
AAPS JOURNALOAAI
AAPS JOURNALIF3.7
OAAI分享收藏分享收藏Systems Pharmacology: Bridging Systems Biology and Pharmacokinetics-Pharmacodynamics (PKPD) in Drug Discovery and Development系统药理学: 桥接系统生物学和药代动力学-药物发现和开发中的药效学 (PKPD)
PREAI
分享收藏International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacologyPHARMACOLOGICAL REVIEWS
PHARMACOLOGICAL REVIEWSIF17.3
PREAI
分享收藏
查看更多内容